Drug delivery systems based on biocompatible imino-chitosan hydrogels for local anticancer therapy

References

• Ahmadi F, Oveisi Z, Mohammadi Samani S, et al. (2015). Chitosan based hydrogels: characteristics and pharmaceutical applications. Res Pharm Sci 10:1–16.
   PubMed Web of Science ®Google Scholar
• Aslam MS, Naveed S, Ahmed A, et al. (2014). Side effects of chemotherapy in cancer patients and evaluation of patients opinion about starvation based differential chemotherapy. J Cancer Ther 5:817–22.
   Google Scholar
• Baerlocher GM, Beer JH, Owen GR. (1997). The anti-neoplastic drug 5-fluorouracil produces echinocytosis and affects blood rheology. Br J Haematol 99:426–32.
   PubMed Web of Science ®Google Scholar
• Bibek S. (2010). Mathematical models used in the drug release studies.
   Google Scholar
• Botham PA. (2004). Acute systemic toxicity–prospects for tiered testing strategies. Toxicol In Vitro 18:227–30.
   PubMed Web of Science ®Google Scholar
• Brandon V, Slaughter SS, Khurshid OZ, et al. (2009). Hydrogels in regenerative medicine. Adv Mater Weinheim 21:3307–29.
   PubMed Web of Science ®Google Scholar
• Buengera D, Topuza F, Groll J. (2014). Hydrogels in sensing applications. Prog Polym Sci 37:1678–719.
   Web of Science ®Google Scholar
• Chandrawati R. (2016). Enzyme-responsive polymer hydrogels for therapeutic delivery. Exp Biol Med (Maywood) 241:972–9.
   PubMed Web of Science ®Google Scholar
• Chenga YH, Tsaiac TH, Jhanb Y-Y, et al. (2016). Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment. Carbohydr Polym 144:390–9.
   PubMed Web of Science ®Google Scholar
• Coccolini F, Gheza F, Lotti M, et al. (2013). Peritoneal carcinomatosis. World J Gastroenterol 19:6979–94.
   PubMed Web of Science ®Google Scholar
• Cojocaru IC, Ochiuz L, Spac A, et al. (2012). The validation of the UV spectrophotometric method for the assay of 5 fluorouracil. Farmacia 3:60.
   Google Scholar
• De Angelis C. (2008). Side effects related to systemic cancer treatment: are we changing the promethean experience with molecularly targeted therapies? Curr Oncol 15:198–9.
   PubMed Web of Science ®Google Scholar
• De Jong WH, Hagens WI, Krystek P, et al. (2008). Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29:1912–9.
   PubMed Web of Science ®Google Scholar
• del Valle LJ, Díaz A, Puiggalí J. (2017). Hydrogels for biomedical applications: cellulose, chitosan, and protein/peptide derivatives. Gels 3:27.
   Web of Science ®Google Scholar
• El-Sayyad HI, Ismail MF, Shalaby FM, et al. (2009). Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats. Int J Biol Sci 5:466–73.
   PubMed Web of Science ®Google Scholar
• Enas MA. (2015). Hydrogel: Preparation, characterization, and applications: a review. J Adv Res 6:105–21.
   PubMed Web of Science ®Google Scholar
• Fallon L. (1973). The crystal and molecular structure of 5-fluorouracil. Acta Crystallogr B Struct Crystallogr Cryst Chem B29:2549.
   Google Scholar
• Foltz CJ. (1999). Guidelines for assessing the health and condition of mice. Resource 28:28–32.
   Google Scholar
• Gary WA, Henise J, Reid R, et al. (2013). Hydrogel drug delivery system with predictable and tunable drug release and degradation rates. Proc Natl Acad Sci USA 110:2318–23.
   PubMed Web of Science ®Google Scholar
• George M, Abraham TE. (2006). Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan—a review. J Control Release 114:1–14.
   PubMed Web of Science ®Google Scholar
• Graham NB, McNeill M. (1984). Hydrogels for controlled drug delivery. Biomaterials 5:27–36.
   PubMed Web of Science ®Google Scholar
• Hoare TH, Kohane DS. (2008). Hydrogels in drug delivery: progress and challenges. Polymer 49:1993–2007.
   Web of Science ®Google Scholar
• Hoffman AS. (2002). Hydrogels for biomedical applications. Adv Drug Deliv Rev 54:3–12.
   PubMed Web of Science ®Google Scholar
• Jalalvandi E. (2017). Hydrogels for biomedical applications: from bio-adhesive to drug delivery [dissertation, doctor of philosophy]. New Zealand: University of Otago.
   Google Scholar
• Jianyu L, Mooney DJ. (2016). Designing hydrogels for controlled drug delivery. Nat Rev Mater 1:16071.
   PubMed Web of Science ®Google Scholar
• Jung J, Kinam Park K. (1998). Smart hydrogels for bioseparation. Bioseparation 7:177–84.
   PubMedGoogle Scholar
• Knuth K, Amiji M, Robinso JR. (1993). Hydrogel delivery systems for vaginal and oral applications: formulation and biological considerations. Adv Drug Deliv Rev 11:137–67.
   Web of Science ®Google Scholar
• Kumar T, Amrita G, Amit T, et al. (2012). Modified chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications. Acta Pharmaceutica Sinica B 2:439–49.
   Web of Science ®Google Scholar
• Lee KY, Mooney DJ. (2001). Hydrogels for tissue engineering. Chem Rev 101:1869–79.
   PubMed Web of Science ®Google Scholar
• Lu Z, Wang J, Wientjes MG, et al. (2010). Intraperitoneal therapy for peritoneal cancer. Future Oncol 6:1625–41.
   PubMed Web of Science ®Google Scholar
• Lupuşoru CE. (2001). Imunofarmacologie. Iaşi: Ed Alfa, 189–195, 299–302.
   Google Scholar
• Marin L, Ailincai D, Morariu S, et al. (2017). Development of biocompatible glycodynameric hydrogels joining two natural motifs by dynamic constitutional chemistry. Carbohydr Polym 170:60–71.
   PubMed Web of Science ®Google Scholar
• Marz L, Piso P. (2015). Treatment of peritoneal metastases from colorectal cancer. Gastroenterol Rep (Oxf) 3:298–302.
   PubMed Web of Science ®Google Scholar
• Mi FL. (2005). Synthesis and characterization of a novel chitosan − gelatin bioconjugate with fluorescence emission. Biomacromolecules 6:975–87.
   PubMed Web of Science ®Google Scholar
• Nabanita S, Aamarjargal S, Niladri R, et al. (2011). Polymeric biomaterial based hydrogels for biomedical applications. J Biomat Nanobiotechnol 2:85–90.
   Google Scholar
• Patel DM, Jani RH, Patel CN. (2011). Design and evaluation of colon targeted modified pulsincap delivery of 5-fluorouracil according to circadian rhythm. Int J Pharma Investig 1:172–81.
   PubMedGoogle Scholar
• Peacman M. (2011). Clinical & Experimental Immunology. British Society of Immunology, New Jersey, USA: Wiley Library.
   Google Scholar
• Richard L, Schilsky MD. (1998). Biochemical and clinical pharmacology of 5-fluorouracil. Oncology (Williston Park, N.Y.) 12:13–28.
   Web of Science ®Google Scholar
• Santos EW, de Oliveira DC, Hastreiter A. (2016). Hematological and biochemical reference values for C57BL/6, Swiss Webster and BALB/c mice. Braz J Vet Res Anim Sci 53:138–45.
   Google Scholar
• Sherbiny IME, Magdi HY. (2013). Hydrogel scaffolds for tissue engineering: progress and challenges. Glob Cardiol Sci Pract 3:316–42.
   Google Scholar
• Spiliotis J, Halkia E, de Bree E. (2016). Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives. Curr Oncol 23:266–75.
   PubMed Web of Science ®Google Scholar
• Wijaya I, Sanityoso A, Lesmana LA. (2012). Acute liver failure related to chemotherapy. Acta Med Indones 44:145–9.
   PubMedGoogle Scholar
• Wolf MF, Andwraon JM. (2012). Practical approach to blood compatibility assessments: general considerations and standards. In: Boutrand J-P, ed. Biocompatibility and performance of medical devices. Cambridge, UK: Woodhead Publishing Ltd. 159–200, 201e–206e.
   Google Scholar
• World Health Organization. (2002). The ten leading causes of death by broad income group. Fact sheet No. 310. WHO Media Centre. Available at: http://www.who.int/mediacentre/factsheets/fs310.pdf
   Google Scholar
• Xu J, Strandman S, Zhu JX, et al. (2015). Genipin-crosslinked catechol-chitosan mucoadhesive hydrogels for buccal drug delivery. Biomaterials 37:395–404.
   PubMed Web of Science ®Google Scholar
• Yang JA, Yeom J, Woo B, et al. (2014). In situ-forming injectable hydrogels for regenerative medicine. Prog Polym Sci 39:1973–86.
   Web of Science ®Google Scholar